Research Article

Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy

Table 2

Antitubercular treatment in the two groups. (PYR = Pyrazinamide; ETHA = Ethambutol; RIF = Rifampicin; ISO = Isoniazid; and CLA = Clarithromycin).

PatientTherapyDurationSide effects

Group A
1ISO6 months
2PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
3RIF3 months
4ISO2 months
5ISO12 months
6PYR ETHA RIF ISO
followed by RIF ISO
0.5 month
1 month
Gastric intolerance
7PYR ETHA RIF ISO
followed by RIF ISO
2 months
3 months
8PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
9PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
Increase of blood liver enzymes
10PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
11ISO4 months
12ISO8 months

Group B
13PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
14PYR ETHA RIF ISONot compliant
15PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
16PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
Optic neuritis
17RIF ETHA AZT12 months
18CLA ETHA12 months
19PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
Itching
20PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
21ISO5 months
22PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
23ISONot compliant
24PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
25PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
Itching
26PYR ETHA RIF ISO
followed by RIF ISO
2 months
4 months
Anemy
27PYR ETHA RIF ISO
followed by RIF ISO
2 months
2 months
28PYR ETHA RIF ISO1 month

Patients with anterior uveitis received topical ophthalmic treatment with mydriatic eye drops associated with topical dexamethasone 0.2% eye drops.